lansoprazole has been researched along with Dysphagia in 10 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The acceptability of pharmaceutical formulations of lansoprazole in capsules and orally disintegrating tables is similar among patients with gastroesophageal reflux disease and associated dysphagia." | 9.14 | [Evaluation of preferences in patients with gastroesophageal reflux disease and dysphagia concerning treatment with lansoprazole orally disintegrating tablets]. ( Armengol, S; Blanco, MA; Heras, J; Mas, M; Mearin, F; Piqué, JM; Plazas, MJ; Prieto, M, 2009) |
| "The acceptability of pharmaceutical formulations of lansoprazole in capsules and orally disintegrating tables is similar among patients with gastroesophageal reflux disease and associated dysphagia." | 5.14 | [Evaluation of preferences in patients with gastroesophageal reflux disease and dysphagia concerning treatment with lansoprazole orally disintegrating tablets]. ( Armengol, S; Blanco, MA; Heras, J; Mas, M; Mearin, F; Piqué, JM; Plazas, MJ; Prieto, M, 2009) |
| "Heartburn, regurgitation and dysphagia were hardly found in any group at 8 weeks after 15 mg or 30 mg lansoprazole treatment." | 5.11 | Management of symptoms in step-down therapy of gastroesophageal reflux disease. ( Iida, T; Kishikawa, H; Mine, S; Tabata, T; Tanaka, Y, 2005) |
| "In our study omeprazole was superior to either lansoprazole or pantoprazole in the maintenance treatment of complicated gastro-oesophageal reflux disease." | 5.08 | A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis. ( Diehl, KL; Geyer, P; Jaspersen, D; Martens, E; Schoeppner, H, 1998) |
| " Proton pump inhibitor (PPI) use in EoE does not lead to histologic improvement; however, the long-term use of PPI on symptoms and prevention of complications has not been evaluated." | 2.77 | Conservative long-term treatment of children with eosinophilic esophagitis. ( Edelman, M; Lai, J; Levine, J; Schuval, SJ, 2012) |
| " Novel dosage formulations of lansoprazole that may be appropriate for patients with dysphagia include the commercially manufactured lansoprazole strawberry-flavored enteric-coated granules for suspension and lansoprazole orally disintegrating tablets." | 2.42 | Management of acid-related disorders in patients with dysphagia. ( Howden, CW, 2004) |
| "Globus pharyngeus and dysphagia are common complaints of patients referred to ear, nose, and throat (ENT) clinics." | 1.38 | Role of flexible transnasal esophagoscopy and patient education in the management of globus pharyngeus. ( Chen, CK; Chen, TM; Cheng, CC; Fang, TJ; Hsiao, HR; Huang, HC; Kuo, YL; Lee, LA; Lee, TJ; Li, HY; Lin, W; Yeh, AR, 2012) |
| "In the dysphagia group, 48 of 54 patients (89%) had edema of the posterior larynx, and 42 of 54 (78%) had laryngopharyngeal sensory deficits." | 1.31 | Laryngopharyngeal sensory deficits in patients with laryngopharyngeal reflux and dysphagia. ( Aviv, JE; Close, LG; Kaplan, ST; Liu, H; Parides, M, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koop, AH | 1 |
| Francis, DL | 1 |
| Blanco, MA | 1 |
| Prieto, M | 1 |
| Mearin, F | 1 |
| Plazas, MJ | 1 |
| Armengol, S | 1 |
| Heras, J | 1 |
| Mas, M | 1 |
| Piqué, JM | 1 |
| Cheng, CC | 1 |
| Fang, TJ | 1 |
| Lee, TJ | 1 |
| Lee, LA | 1 |
| Chen, TM | 1 |
| Chen, CK | 1 |
| Yeh, AR | 1 |
| Huang, HC | 1 |
| Hsiao, HR | 1 |
| Lin, W | 1 |
| Kuo, YL | 1 |
| Li, HY | 1 |
| Levine, J | 1 |
| Lai, J | 1 |
| Edelman, M | 1 |
| Schuval, SJ | 1 |
| Ibrahim, A | 1 |
| Cole, RA | 1 |
| Qureshi, WA | 1 |
| Helaly, AZ | 1 |
| Jamecci, A | 1 |
| Graham, DY | 1 |
| Ayub, K | 1 |
| Howden, CW | 1 |
| Mine, S | 1 |
| Iida, T | 1 |
| Tabata, T | 1 |
| Kishikawa, H | 1 |
| Tanaka, Y | 1 |
| Kouklakis, G | 1 |
| Moschos, J | 1 |
| Paikos, D | 1 |
| Tagarakis, G | 1 |
| Rouska, E | 1 |
| Mpoumponaris, A | 1 |
| Lyrantzopoulos, N | 1 |
| Molyvas, E | 1 |
| Minopoulos, G | 1 |
| Jaspersen, D | 1 |
| Diehl, KL | 1 |
| Schoeppner, H | 1 |
| Geyer, P | 1 |
| Martens, E | 1 |
| Aviv, JE | 1 |
| Liu, H | 1 |
| Parides, M | 1 |
| Kaplan, ST | 1 |
| Close, LG | 1 |
1 review available for lansoprazole and Dysphagia
| Article | Year |
|---|---|
Management of acid-related disorders in patients with dysphagia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Age Factors; Aged; Aged, 80 an | 2004 |
5 trials available for lansoprazole and Dysphagia
| Article | Year |
|---|---|
[Evaluation of preferences in patients with gastroesophageal reflux disease and dysphagia concerning treatment with lansoprazole orally disintegrating tablets].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Cross-Over Studies; Deglutition Disorders; Female; Gastroes | 2009 |
Conservative long-term treatment of children with eosinophilic esophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Child; Child, Preschool; Deglutition Disorders; Endoscopy; | 2012 |
Schatzki's ring: to cut or break an unresolved problem.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Deglutition Disorders; Dilatation; Electrosurgery; En | 2004 |
Management of symptoms in step-down therapy of gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Deglutition Disorders; Endosonography; Enzyme Inhibit | 2005 |
A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Deglutition | 1998 |
4 other studies available for lansoprazole and Dysphagia
| Article | Year |
|---|---|
A Rare Case of Eosinophilic Esophagitis and Dysphagia Lusoria.
Topics: Adult; Computed Tomography Angiography; Deglutition Disorders; Endoscopy, Digestive System; Eosinoph | 2020 |
Role of flexible transnasal esophagoscopy and patient education in the management of globus pharyngeus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Deglutition Disorders; Esophagoscopy; Female; | 2012 |
Evidence for the ''paradox'' association between hypertensive lower esophageal sphincter and gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Angina Pectoris; Deglutition Disorders; Esophageal S | 2008 |
Laryngopharyngeal sensory deficits in patients with laryngopharyngeal reflux and dysphagia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Deglutition Disorders; Fema | 2000 |